Clinical Trials Directory

Trials / Unknown

UnknownNCT00491270

Bacterial Vaginosis Screening and Treatment to Reduce Infective Complications, Abortion and Preterm Delivery

Status
Unknown
Phase
Phase 3
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Western Galilee Hospital-Nahariya · Other Government
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

To determine whether screening of pregnant women with history of previous preterm delivery or with premature contractions for bacterial vaginosis using VS-SENSE, and treatment of positive women will reduce the risk of spontaneous preterm birth.

Detailed description

This is an open-label, comparative, and prospective study. Pregnant women, pregnancy week 26 to 36+6, between the ages 18-45, who were hospitalized in the high risk department, with history of previous preterm delivery and/or with premature contractions. Patient with premature ruptured membrane will be excluded. In the hospital pregnant women with history of previous preterm delivery or with premature contractions, (participants) will be examined by speculum with no lubricant, The clinician will use the VS-SENSE to sample vaginal secretions and will immediately observe and record the color obtained.Should the VS-SENSE produce positive results the physician will consider giving clindamycin treatment.

Conditions

Interventions

TypeNameDescription
DEVICEVS SenseAn applicator to diagnose pH increase above 5.2

Timeline

Start date
2011-01-01
Primary completion
2012-01-01
Completion
2013-08-01
First posted
2007-06-26
Last updated
2011-05-25

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00491270. Inclusion in this directory is not an endorsement.